2026-01-28 - Analysis Report
**Company Overview**
Lam Research is a manufacturer of semiconductor equipment used in the fabrication of integrated circuits.

**Return Rate Comparison**

| Ticker | Cumulative Return |
| --- | --- |
| LRCX | 954.15% |
| VOO | 128.51% |

Divergence (max: 784.50, min: -6.80, current: 757.70, relative divergence: 96.60%)

**Alpha, Beta Analysis**

| Year | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 14.0% | 33.7% | 5.0% | 1.6 | 17.2B |
| 2017-2019 | 89.0% | 33.7% | 64.0% | 1.7 | 36.9B |
| 2018-2020 | 147.0% | 44.4% | 123.0% | 1.5 | 59.5B |
| 2019-2021 | 293.0% | 44.4% | 229.0% | 1.6 | 90.7B |
| 2020-2022 | 2.0% | 54.3% | -3.0% | 1.6 | 53.0B |
| 2021-2023 | 65.0% | 54.3% | 47.0% | 1.8 | 98.8B |
| 2022-2024 | -11.0% | 45.7% | -41.0% | 1.9 | 91.1B |
| 2023-2025 | 482.0% | 46.1% | 406.0% | 2.0 | 215.9B |

**Recent Stock Price Fluctuations**

| Moving Average | Value |
| --- | --- |
| 5-day SMA | $225.67 |
| 20-day SMA | $208.24 |
| 60-day SMA | $175.84 |
| Close | $238.46 |
| Last-market | $238.46 |

**RSI, PPO, Delta_Previous_Relative_Divergence, Expected_Return Analysis**

* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* RSI: 67.75
* PPO: 0.06
* Recent (20 days) relative divergence change: -3.40 (worsening)
* 7-day Rank change: 12 (rank up)
* 7-day Dynamic Expected Return change: 38.30 (improving)
* Expected Return: 49.10% (compared to S&P 500)

**News & Significant Events (Yahoo Finance)**

* Lam Research leans on AI tailwinds as China weighs on outlook (LRCX:NASDAQ)
* Why Is Lam Research (LRCX) Stock Soaring Today
* Lam Research (NASDAQ:LRCX) Reaches New 1-Year High After Analyst Upgrade
* LRCX Likely to Beat Q2 Earnings Estimates: Should You Buy the Stock?
* Lam Research Corp (NASDAQ:LRCX) Shows Strong Fundamentals and Technical Momentum for Growth Investors
* What Makes Lam Research (LRCX) a Strong Momentum Stock: Buy Now?

**Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.72 (~Buy)
- Opinions: 31
- Target Price (avg/high/low): 215.35 / 265.00 / 115.00

**Recent Earnings Analysis**

| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-24 | $1.24 | $5.32B |
| 2025-04-25 | $1.04 | $4.72B |
| 2025-01-31 | $0.93 | $4.38B |
| 2024-10-28 | $0.86 | $4.17B |

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $5.32B | 50.43% |
| 2025-06-30 | $5.17B | 50.08% |
| 2025-03-31 | $4.72B | 49.02% |
| 2024-12-31 | $4.38B | 47.37% |
| 2024-09-30 | $4.17B | 48.05% |

**Capital and Profitability**

| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $10.19B | 15.39% |
| 2025-06-30 | $9.86B | 17.44% |
| 2025-03-31 | $9.51B | 13.99% |
| 2024-12-31 | $8.81B | 13.52% |
| 2024-09-30 | $8.47B | 13.18% |

**Comprehensive Analysis**

Lam Research has shown strong growth in recent years, with a cumulative return of 954.15% compared to the S&P 500's 128.51%. The company's Alpha, Beta analysis reveals a strong performance in various periods, with a maximum CAGR of 482.0% and a minimum MDD of 2.0%. The recent stock price fluctuations show a positive trend, with moving averages indicating a potential increase in price. The RSI and PPO indicators suggest a neutral to bearish trend, while the Market Risk Indicator is at a moderate level. The news and significant events section highlights several positive articles about the company, indicating potential growth. Analyst opinions are generally positive, with a buy recommendation and a target price of $215.35. The recent earnings analysis shows a steady increase in revenue and EPS. The revenue and profitability section highlights a strong profit margin, while the capital and profitability section reveals an increase in equity and a steady ROE. Overall, Lam Research appears to be a strong candidate for investment.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.